Article Details
Retrieved on: 2022-12-03 09:33:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In March 2022, the FDA designated Pfizer's genetically engineered RSV vaccine as a “breakthrough therapy,” which will put the review process on a fast ...
Article found on: sharylattkisson.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here